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OBJECTIVES The goal of this study was to evaluate percutaneous interventional and minimally invasive
surgical closure of secundum atrial septal defect (ASD) in children.
BACKGROUND Concern has surrounded abandoning conventional midline sternotomy in favor of the less
invasive approaches pursuing a better cosmetic result and a more rational resource utilization.
METHODS A retrospective analysis was performed on the patients treated from June 1996 to December
1998.
RESULTS One hundred seventy-one children (median age 5.8 years, median weight 22.1 kg) underwent
52 device implants, 72 minimally invasive surgical operations and 50 conventional sternotomy
operations. There were no deaths and no residual left to right shunt in any of the groups. The
overall complication rate causing delayed discharge was 12.6% for minimally invasive surgery,
12.0% for midline sternotomy and 3.8% for transcatheter device closure (p , 0.01). The mean
hospital stay was 2.8 6 1.0 days, 6.5 6 2.1 days and 2.1 6 0.5 days (p , 0.01); the
skin-to-skin time was 196 6 43 min, 163 6 46 min and 118 6 58 min, respectively (p ,
0.001). Extracorporeal circulation time was 49.9 6 10.1 min in the minithoracotomy group
versus 37.2 6 13.8 min in the sternotomy group (p , 0.01) but without differences in aortic
cross-clamping time. Sternotomy was the most expensive procedure (15,000 A 6 1,050 A vs.
12,250 A 6 472 A for minithoracotomy and 13,000 A 6 300 A for percutaneous devices).
CONCLUSIONS While equally effective compared with sternotomy, the cosmetic and financial appeal of the
percutaneous and minimally invasive approaches must be weighed against their greater
exposure to technical pitfalls. Adequate training is needed if a strategy of surgical or
percutaneous minimally invasive closure of ASD in children is planned in place of
conventional surgery. (J Am Coll Cardiol 2001;37:1707–12) © 2001 by the American
College of Cardiology
Conventional surgical closure through midline sternotomy
is considered the gold standard in the treatment of children
with secundum type atrial septal defect (ASD) due to very
low mortality and morbidity rates among these children and
the availability of long-term follow-up data available for this
procedure. Recent advances in the use of minimally invasive
surgical techniques (characterized by very small incisions
with minimal exposure of the operative field) and of
interventional percutaneous device applications are now
challenging the role of the conventional approach, especially
in the cases of small to medium sized defects. Supposed
advantages of the new approaches include a more cosmetic
skin incision, less postoperative pain, shorter hospital stay
and earlier return to physical activity (1–5). However,
minimally invasive surgery appears more technically de-
manding than conventional surgery, while percutaneous
closure entails the need for otherwise unnecessary intracar-
diac prostheses. Therefore, the issue of abandoning the
well-established midline sternotomy approach in favor of
the newer techniques remains highly controversial. The
main argument is whether cosmetic and financial goals
should divert the management philosophy toward more
audacious solutions.
From March 1996 to November 1998, our institution
offered three different techniques to pediatric patients with
secundum ASD, that is, conventional sternotomic surgery,
minimally invasive surgery and interventional device-
closure. We retrospectively analyzed our experience regard-
ing the efficacy and safety of minimally invasive surgery and
percutaneous devices with respect to a control group of
patients of similar age and weight treated by conventional
midline sternotomy.
Patient selection. All 171 consecutive patients with an
isolated secundum ASD referred to our institution from
March 1996 to December 1998 were included. Patients
with partial anomalous pulmonary venous return or other
associated defects were excluded. During this time frame,
there was no established institutional policy for selecting any
of the three available techniques for ASD closure. However,
patients with an isolated and centrally located secundum
ASD not exceeding a size of 20 mm and at a safe distance
from the pulmonary veins, the mitral valve and the caval
veins were generally referred for device closure. All candi-
dates for percutaneous ASD closure had a 24-h day-hospital
admission before the procedure for transesophageal echo-
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cardiography (TEE) screening to minimize the risk of
aborted procedures in the catheterization laboratory. With
respect to surgical indication for ASD closure, the choice of
a minimally invasive surgical approach was initially based
mostly on the personal confidence of the surgeon with this
technique or, occasionally, on the parental preference.
METHODS
The following parameters were calculated: 1) mortality and
morbidity (including all events causing a delayed discharge
of the patient); 2) length of the procedure, that is, skin-to-
skin time for the surgical procedures and catheter in-
catheter out for the percutaneous approach (anesthesia
induction time was not taken into account); 3) cardiopul-
monary bypass and aortic cross-clamp times for the surgical
groups; 4) duration of hospitalization (the amount of time
from the procedure until the discharge from the hospital);
and 5) costs.
Operative techniques. PERCUTANEOUS CLOSURE. The
technique was the same for each type of device and was
always carried out by the same group of cardiologists.
After routine cardiac catheterization with oxymetric and
pressure recordings, a Mullins sheath was advanced over an
exchange guidewire into the left atrium. The device was
inserted into the sheath and carefully deployed under TEE
surveillance. Device release was followed by control right-
atrial angiography. Fluoroscopic equipment was the same
throughout all procedures, and, for echocardiographic as-
sessment, a Sonos 2500 (Hewlett & Packard, Amsterdam,
The Netherlands) echocardiograph was used. Antibiotic
prophylaxis was given for 48 h, and aspirin was administered
for six months. The follow-up schedule included a full
clinical and transthoracic echocardiography (TTE) evalua-
tion at one, three and six months after the procedure and
yearly thereafter.
Minimally invasive surgery. Minimally invasive surgery
was carried out by all members of the surgical team (n 5 7).
Information about the mean size of the defect is not
available. The patient was placed with the right side elevated
by 30 degrees. A 5- to 6-cm anterolateral right thoracotomy
incision was performed at the level of the fifth intercostal
space (Fig. 1). The chest was entered through the third
intercostal space. The pericardium was opened at least 2 cm
anterior and parallel to the phrenic nerve, and a piece of it
was harvested for later use as a patch. The ascending aorta
was cannulated first, followed by cannulation of the inferior
vena cava. A mildly-to-moderately hypothermic (30°C)
cardiopulmonary bypass was instituted, and the superior
vena cava was directly cannulated. Under mild general
hypothermia, the ascending aorta was cross-clamped, and
crystalloid cardioplegic solution was infused into the aortic
root. The defect was closed through a right atriotomy. After
discontinuation of the cardiopulmonary bypass, the thora-
cotomy was closed in a routine fashion.
The follow-up schedule after discharge was clinical and
echocardiographic evaluations after one week, one month,
six months and yearly thereafter.
Midline sternotomy. The heart was reached through a
classic midline sternotomy. Mildly hypothermic cardiopul-
monary bypass was instituted through aortic and bicaval
cannulations. During a short period of aortic cross-
clamping, transatrial defect closure was accomplished. The
follow-up schedule was similar to that for minimally inva-
sive surgery.
Cost estimation. Costs were calculated on an individual
basis to produce a “case cost” (6), which is the sum of the
variable individual direct costs (i.e., generic medical supplies
like oxygen masks and intubation sets, delivery systems and
devices in the case of percutaneous closure, oxygenator and
bypass equipment in the case of surgery, time spent in the
catheterization laboratory [operating room, intensive care
unit, ward]). The costs of laboratory tests were not taken
into account. Since the national health system in Italy is not
comparable with a US Health Management Organization
style system, we preferred avoiding calculation of the impact
Abbreviations and Acronyms
ASD 5 atrial septal defect
A 5 Euro
TEE 5 transesophageal echocardiography
TTE 5 transthoracic echocardiography
Figure 1. A six-year-old child on the second postoperative day after
minimally invasive surgical repair of a secundum atrial septal defect. The
limited lateral right thoracotomy and the entry hole of the chest tube are
clearly visible.
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of the personal fees of the physicians, so they are not
included in the analysis. For the same reason, we excluded
fixed direct costs and indirect costs. All values are expressed
using the current standard European currency (Euro).
Statistical analysis. Statistical analysis was performed by
analysis of variance (ANOVA) and Bonferroni t test in
comparison with Bartlett’s test for equal variances or the
Kruskal-Wallis test in case of non-Gaussian distribution of
the population (GraphPad Prism 3.0 statistical package,
GraphPad Software Inc., San Diego, California). A p
,0.05 was considered to be significant.
RESULTS
Patient demographics. Among 171 consecutive patients
with isolated secundum ASD, 52 were evaluated as poten-
tial candidates for catheter closure of the defect but were
secondarily referred to surgery because of unfavorable anat-
omy of the defect found at conventional TTE or TEE,
while 67 were treated by primary surgical repair due to
parental decision or lack of confidence of the referring
cardiologist towards the percutaneous protocol.
Percutaneous closure was considered feasible in 70 chil-
dren, but 18 were crossed over to the surgical groups because
the defect was too large at balloon stretching (n 5 17) or too
close to the mitral valve (n 5 1) as detected during the
invasive diagnostic procedure. Cardiac catheterization and
subsequent device deployment attempt was finally carried
out in 52 children (median 7.0 years, median weight 23 kg)
using two types of devices, the Amplatzer (AGA Medical
Corporation, Golden Valley, Minnesota) (41 patients) and
the Microvena Angel Wings (Microvena Corporation, Vad-
nais, Minnesota) (11 patients). Average ASD diameter at
TEE was 12.0 6 3.6 mm (14.6 6 4.1 mm mean stretch
diameter), and mean Qp/Qs was 1.66 6 0.57. Mean
follow-up was 41 6 2 months for the patients receiving the
Angel Wings device and 18 6 13 months for the patients
receiving the Amplatzer device.
Minimally invasive repair was accomplished from June
1996 to December 1998 in 71 patients (median age 5.1
years, median weight 20.5 kg) through a right submammary
minithoracotomy by an autologous pericardial patch closure
in 66 cases and direct closure in five cases. Femoral arterial
cannulation was necessary in six cases (8.4%). Median
follow-up time for this group was 19 months.
During the time frame considered for the study, conven-
tional midline sternotomy repair was carried out in 50 cases
(median age 5.1 years, median weight 18 kg). In 48 patients,
a pericardial patch was used for repair, while in the other
two, repair was accomplished by direct suture. Information
about the mean size of the defects for the patients treated by
surgery is not available. There were no significant differ-
ences among the three groups of patients in terms of age and
weight.
Mortality and morbidity. There were no early or late
deaths.
Percutaneous closure. Two patients (3.8%) experienced
complications. One patient had a pericardial tamponade 6 h
after the implant of an Angel Wings device, requiring
emergency surgery. A perforation was found on the anterior
aortic wall, probably caused by the device.
In the other patient, a premature unscrewing from the
delivery system of an Amplatzer device occurred, due to a
series of maneuvers aimed at reversing an occurrence of the
so-called “cobra” shaping of the device. Despite several
attempts, the device failed to regain a flat shape and could
not be adequately positioned across the atrial septum. Due
to a large residual shunt, the patient had to be operated on
the same day. There were no vascular complications.
Minimally invasive thoracotomy. The overall rate of com-
plications was 9.8% (7/71 patients), with four early (5.6%)
and three late (4.2%) events. The short-term complications
requiring a prolonged hospitalization were bleeding in one
patient and transient sick sinus syndrome in three patients.
One late complication requiring readmission to the hos-
pital consisted in patch dehiscence of the suture line with
significant residual left-to-right shunt requiring reoperation
(through the same minithoracotomy approach) after two
weeks. Another two patients, one with postoperative pneu-
mothorax and one with pericardial effusion, were treated
conservatively and discharged after three and six days,
respectively.
Midline sternotomy. The overall rate of complications was
12% (6/50). Only one patient (2%) had an early event (atrial
fibrillation lasting for 48 h with spontaneous reversion to
sinus rhythm). The other five (10%), in the days after
surgery, had transient atrial arrhythmias (one case), pro-
longed pericardial effusions (three cases) treated with ste-
roids or aspirin and sternal wire granuloma (one case).
Efficacy. No significant residual shunts were observed in
this group of patients. In four cases treated with the
Amplatzer device, there was a trivial to mild shunt imme-
diately after the procedure, which disappeared after 24 h as
shown by the follow-up TTE. There were no residual or
recurrent shunts within the surgical groups.
Hospital stay. The sternotomy group required the longest
hospitalization time (6.5 6 2.1 days) followed by the
minimally invasive (2.8 6 1.0 days) and percutaneous device
(2.1 6 0.5 days) groups. The differences between the
conventional and both the minimally invasive and percuta-
neous approaches were highly significant (p , 0.01).
Procedure time. The minimally invasive approach was
more time consuming (196 6 43 min) than either the device
approach (118 6 58 min, p , 0.001) or the sternotomy
approach (163 6 46 min, p , 0.01). The difference between
the interventional and sternotomy groups was highly signif-
icant (p , 0.01).
Extracorporeal circulation and cross-clamping time.
Minithoracotomy required longer extracorporeal circulation
times than cases treated with sternotomy (49.9 6 10.1 min
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vs. 37.2 6 13.8 min, p , 0.01). However, there were no
differences regarding the length of cross-clamping times
(19.6 6 4.1 min vs. 17.9 6 5.0 min, p . 0.05).
Costs. Costs did not differ between the percutaneous and
minimally invasive techniques (12,250 Euro [A] 6 472 A vs.
13,000 A 6 300 A), while sternotomy was significantly more
costly (15,000 A 6 1,050 A, p , 0.01). Costs for the
percutaneous group include the two cases submitted to
surgery and represent a mean of the two types of devices
used. The Amplatzer and Angel Wings had nearly the same
individual cost (including selling price and delivery equip-
ment).
DISCUSSION
Minimally invasive (possibly video-assisted) repairs of
ASDs (7) and other types of congenital heart defects have
recently been reported but are considered highly controver-
sial (8). The claimed advantages of minimally invasive
surgical techniques are better cosmetic appearance and
reduction of pain. These patients, compared with those
undergoing transsternotomy ASD closure, supposedly have
a smoother postoperative course and an earlier discharge
time.
On the other hand, the increasing use of percutaneous
ASD closure systems has proven that selected patients may
be treated with as good results as those of conventional
surgery, yet implying a shorter hospital stay and no scar at
all. The related economic benefits further push the current
trend towards fast-track strategies for the repair of uncom-
plicated secundum ASDs (9). Moreover, recent studies
report a subtle, but not minimal, superiority in the intellec-
tual and psychological scores of patients treated by percu-
taneous device implantation compared with those treated by
surgery (i.e., using extracorporeal circulation) (10).
However, minimally invasive surgery may sometimes
become quite challenging with complex arterial and venous
cannulations and with a less-than-optimal view of the
operating field, possibly implying unwarranted operating
risks. Moreover, there is still some debate on whether a
lateral minithoracotomy or a lower ministernotomy should
be the incision sites of choice. A recent article strongly
disputes the “minimal” aspect of reduced sternotomy tech-
niques, showing similar results in terms of hospitalization,
pain scores and stress indexes in a randomized trial versus
conventional full-length sternotomy (11).
On the other side, percutaneous ASD closure relies on
the use of prosthetic material inside the heart, needs an
adequate training for the operator and presents several
structural pitfalls (e.g., potential device fracture, emboliza-
tion or thromboembolic accidents).
Therefore, it is still unclear whether minimally invasive
surgery or device implantation will definitively provide an
adequate replacement of conventional surgery as primary
choice(s), especially in children. Berger and coworkers (12)
recently analyzed their experience comparing a subset of
patients undergoing percutaneous defect closure with an-
other group submitted to surgery. Their study comprised
adults and older children (median 12 years), and no distinc-
tion was made between lateral minithoracotomy and con-
ventional sternotomy within the surgical group, leading to
an “unfair” comparison of hospital stay and resource utili-
zation between the percutaneously and surgically treated
groups. In addition, follow-up time was very limited for
both groups. Since at our institution these three techniques
were distinctively and simultaneously carried out for a
limited time frame, we aimed at comparing the results using
efficacy and safety parameters common to all three proce-
dures (incidence of residual shunts and complication rates)
as well as parameters concerning financial and management
aspects.
Morbidity. The number of complications was significantly
higher in the surgical groups compared with the percutane-
ous group, leading to a generally longer hospital stay and a
greater economical impact.
However, if one considers the severity of complications,
the two serious events that occurred in the percutaneous
group fairly outweigh the events that occurred in the
surgical groups, making the statistical difference somewhat
misleading. On the other hand, both events within the
catheterization group should probably be considered as
relatively rare and unlikely to recur.
It is noteworthy that the minimally invasive group had an
incidence of complications similar to that of the sternotomy
group (12% vs. 12.5%, p . 0.05). Again, this comparison is
meaningful only with respect to economical issues (i.e.,
considering all the events producing a prolonged hospital-
ization). In fact, the patch dehiscence in one case of the
minithoracotomy group should be regarded by far as the
most important of all postsurgical problems, yet necessitat-
ing a re-do ASD closure. Although this case was operated
on early in our experience, we acknowledge that limited
surgical field, typical of lateral minithoracotomy, may have
had an impact on the determination of a fractured suture
line, ultimately resulting in patch dehiscence.
All things considered, stratifying complications by pure
clinical impact score, conventional surgery still emerges as
the safest technique (0% vs. 2.8% of minimally invasive
surgery vs. 3.8% of the interventional technique).
Efficacy. All patients eventually had successful closure of
their defect. Based on our data showing a 100% closure rate
in the percutaneous group, we endorse the equivalence in
efficacy of the three different approaches. However, we are
aware that the midterm follow-up results available from the
literature concerning the Amplatzer system show a 92% to
95% complete closure rate. It should be emphasized, how-
ever, that there are no established criteria yet on whether to
consider “successful closure” of an ASD only a “complete
closure” or whether to include among successes those cases
in which there is the presence of a trivial residual shunt. In
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this respect, more long-term follow-up data from larger
series seem necessary.
Hospital stay. In our series, conventional sternotomy re-
quired a significantly longer hospitalization than the other
two techniques. Whereas other groups report very short
recovery periods for this kind of approach, at least three to
four days were necessary for our patients to be painless and
fully mobilized, as well as to regain an adequate respiratory
function. In addition, many of these patients came from a
long distance and we have generally preferred to prolong
postoperative observation before discharging them back
home. Again, in our series, minimally invasive surgery
yielded similar results in length of hospitalization with
respect to the percutaneous approach (despite a statistically
significant difference).
Procedure time. We evaluated the procedure time of the
three different treatments as a part of the financial assess-
ment section of our study. Excluding the anesthesia induc-
tion time (which we assumed as being similar for all the
procedures), the significantly lower procedure time of the
interventional group reflects a lower degree of resource
utilization. This holds even more true if one considers that
11 patients of the interventional group were treated with the
Microvena Angel Wings device which, as previously re-
ported by our group (13), is associated with a significantly
longer procedure than with the Amplatzer device.
Extracorporeal circulation and aortic cross-clamping.
The longer extracorporeal circulation time required by the
minithoracotomy approach compared with the cases treated
through a sternotomy relates to a greater technical challenge
in setting up a full cardiopulmonary bypass but, with
increasing experience, these maneuvers have taken a pro-
gressively shorter time.
Clearly, once the aortic cross-clamp was in place, the
actual exposing and closing of the defect was no more
complex than it was with the sternotomy approach, as
demonstrated by the similar cross-clamping times.
Costs. In this study, costs relate to the local health man-
agement system and should not be viewed as an absolute
indication, but rather as relative economic impact, of each of
the three different techniques. In our opinion, the evaluation
of variable costs without the fixed component and the
physician’s fees makes our evaluation applicable, even if
cautiously, on a broader extent and independently from our
local health and reimbursement system. Interestingly, the
absolute mean cost of our cases treated by conventional
midline sternotomy is not very different from that reported
for patients operated on in the U.S. (14). The higher costs
in the sternotomy group were largely due to the longer
hospital stay. It is noteworthy that there was no significant
difference in costs between the minimally invasive and
catheterization groups. In fact, the high cost of percutane-
ous devices was counterbalanced by the need for extracor-
poreal circulation equipment and longer procedure time in
the minithoracotomy group.
Study limitations. This is not a randomized study, and
part of the patients submitted to catheterization procedures
were selected on the basis of the anatomic features of their
defects. However, while not being as reliable as a true
statistic randomization, the time frame selected for data
collection and the fact that there were no significant
differences in age and weight among the three groups
provide some support for assuming a fair comparison of
results among the three approaches. On the other side, true
randomization of patients for catheterization versus surgical
procedures or for limited surgical access versus conventional
midline sternotomy is not easily feasible, especially in the
presence of determined parents denying the concept of
chance while deciding the future of their children.
Another limitation of our study was the probable bias
introduced by the absence of standardized guidelines for
discharge of our patients after surgery. While it is true that
the minimally invasive group was characterized by a signif-
icantly reduced length of hospitalization, at least some of
the children in the sternotomy group were discharged from
the hospital after no less than seven to eight days just for
observance of old management protocols. Indeed, patients
treated by minithoracotomy never had to wait for removal of
the pacing wires, which were often applied instead in
patients treated by sternotomy. It is, therefore, questionable
whether such a long time is really required for patients
treated by conventional sternotomy surgery, and this is
confirmed by Laussen et al.’s (11) article showing the
absence of any significant statistical difference regarding
many variables, including hospital stay, in a prospective
evaluation of patients randomized for ministernotomy or
conventional extended sternotomy. It is interesting that a
recent review on minimally invasive surgical repair of 115
patients with secundum ASD yields a median hospital stay
of four days (14). Despite all hinted biases, in our opinion,
a moderately shorter hospital stay of the sternotomy patients
would not have severely impaired our evaluation, especially
for concerns of complication rate, efficacy and surgery-
related variables.
Another limitation of this study may be our preference
for a minithoracotomy, an approach that has been criticized
due to the risk of mammary and pectoral maldevelopment,
especially if performed before the clear development of the
submammary crease (15,16). We do not have short-term
evidence of these kinds of problems and firmly believe that
the submammary incision along the fifth intercostal space is
safe in this regard.
Conclusions. While equally effective compared with ster-
notomy, the cosmetic, financial and organizational appeal of
both the percutaneous and minimally invasive approaches
for ASD closure must be weighed against their undoubtedly
greater exposure to technical pitfalls. Therefore, adequate
training and expertise must be a prerequisite if a strategy of
surgical or percutaneous minimally invasive approach is
selected in place of conventional midline sternotomy surgery
for children with ASD.
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